查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088773

獸用感染疾病物市場：2026-2032年全球市場預測（依產品類型、給藥途徑、動物類型、通路及應用分類）

Veterinary Anti-infectives Market by Product Type, Route Of Administration, Animal Type, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸用感染疾病物市場將成長至 230.7 億美元，複合年成長率為 14.03%。

主要市場統計數據
基準年 2025 92億美元
預計年份：2026年 104.5億美元
預測年份：2032年 230.7億美元
複合年成長率 (%) 14.03%

獸用感染疾病物市場執行摘要

獸用感染疾病物在動物健康、食品安全和感染疾病控制中發揮著至關重要的作用，涵蓋了用於畜禽、家禽、水產養殖和通用動物的抗菌、抗真菌藥物和抗病毒藥物及相關療法。需求成長的促進因素包括動物性蛋白質消費量增加、寵物數量成長、獸醫護理水平的提高以及減少農場、水產養殖系統和動物醫院中疾病相關生產力損失的需要。

獸用感染疾病物市場的變革性變化

獸用感染疾病物領域正從注重高劑量治療轉向負責任和精準用藥。諸如美國獸用飼料指令（VFD）、限制將具有重要醫療價值的抗生素用於生產目的、歐盟禁止常規使用抗生素進行預防以及全球抗菌素抗藥性監測計劃等監管措施，正在加速向製劑控制、獸醫合理用藥管理以及治療合理性記錄的轉變。

人工智慧對獸用感染疾病物的累積影響

人工智慧 (AI) 透過改善疾病檢測、抗藥性預測、藥物安全監測和治療決策支持，正在為獸用感染疾病物領域創造累積價值。 AI 驅動的影像、感測器數據、電子健康記錄、診斷平台和農場管理系統能夠識別感染的早期徵兆，幫助獸醫更快地進行干預，同時促進更精準地使用抗生素。

主要獸用感染疾病物市場的關鍵區域洞察

亞太地區仍然是獸用感染疾病物的重點關注區域，這主要得益於中國、印度、日本、韓國、澳大利亞和東南亞大規模的牲畜存欄量、集約化水產養殖、伴侶動物護理的擴展以及獸醫基礎設施的加強。該地區的動物健康重點受家禽和生豬生產、酪農發展、出口導向水產養殖以及對殘留物和抗生素使用監管力度加大的影響。北美地區的特點是獸藥分銷管道成熟、寵物相關支出強勁、美國食品藥品監督管理局（FDA）和加拿大法律規範、抗生素銷售報告透明，以及生產者對牲畜健康管理、診斷和生物安全項目的投入。拉丁美洲地區，以巴西和墨西哥龐大的牛肉、家禽、豬肉和乳製品產業為支撐，繼續將出口合規、牲畜生產力和疾病預防視為該地區負責任地使用感染疾病物的關鍵促進因素。

我們集團對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵見解

東協的需求主要受家禽、生豬、​​水產養殖和乳製品產業的擴張所驅動，各國政府也日益重視將食品安全、殘留檢測和動物健康計畫與合理使用抗生素結合。該地區多樣化的生產系統催生了對價格合理、物種適用且品質有保證的獸用抗生素的需求，而獸醫指導和診斷服務的改善也為此提供了支持。海灣合作理事會（GCC）成員國則專注於糧食安全、進口種畜、酪農現代化、駱駝和馬匹健康管理以及規範的獸醫行業，因此對具有安全性、可追溯性和殘留特徵的高品質感染疾病物有著迫切的需求。

主要國家獸用感染疾病物的發展趨勢

美國和加拿大受益於先進的獸醫基礎設施、對伴侶動物的投入、畜牧生物安全計劃以及抗菌藥物銷售和分銷的透明報告系統。同時，墨西哥和巴西是重要的畜牧業主導市場，其發展受出口合規、家禽和牛肉生產、酪農現代化以及畜群生產力等因素的影響。在歐洲，英國、德國、法國、義大利和西班牙擁有強大的獸醫網路，並期望嚴格遵守合理使用抗生素、做好殘留管理，以及建立成熟的畜牧和伴侶動物照護系統。另一方面，俄羅斯則持續受到國內動物性蛋白質生產、進口替代趨勢以及在全部區域維持動物用藥品供應需求的影響。

獸用感染疾病物產業領導者使用的實用建議

產業領導者應將合理使用抗菌藥物作為商業性優勢，並優先投資於快速診斷、基於藥敏試驗的製劑工具、獸醫教育以及標靶治療產品。產品系列策略應減少對頻譜抗菌藥物的依賴，並強調清晰的標籤、具體的劑量、遵守停藥間隔、藥物動力學證據、偏好、依從性以及臨床實踐中的安全性經驗數據。

深入了解獸用感染疾病物的調查方法

本執行分析基於二手研究，數據來自監管機構發布的出版刊物、獸醫指南、抗菌素抗藥性監測計畫、動物健康政策文件、同行評審文獻以及美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、世界動物衛生組織 (WOAH)、世界衛生組織 (WHO)、聯合國糧食及農業機構 (FAO)、歐洲食品安全機構 (EFSA) 等。市場解讀考慮了動物數量趨勢、動物性蛋白質生產、水產養殖發展、寵物照護需求、製劑法規、殘留控制、藥品安全監測要求以及區域市場進入趨勢。

結論：獸用感染疾病物負責任的成長

獸用感染疾病物市場正邁入一個更規範化的時代，如何在滿足動物健康需求的同時緩解抗生素抗藥性問題是產業發展的關鍵。由於感染疾病直接影響畜牧業生產力、伴侶動物福利、水產養殖成果、價值鏈的持續性，市場需求依然強勁。然而，未來市場規模預計將越來越受到精準性、合規性、與診斷技術的整合以及循證治療的驅動。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用感染疾病物市場：依產品類型分類

  • 抗生素
    • Aminoglycosides抗生素
    • BETA-內醯胺
    • Fluoroquinolones抗生素
    • 大環內酯類
    • 磺胺類藥物藥物
    • 四環黴素
  • 抗真菌藥物
    • 唑類藥物
    • Polyenes
  • 驅蟲
    • 殺蟎劑
    • 驅蟲
    • 殺蟲劑

第8章 獸用感染疾病物市場：依給藥途徑分類

  • 注射藥物
    • 肌肉內部
    • 靜脈
    • 皮下
  • 口服
    • 顆粒
    • 粉末
    • 懸浮液
    • 藥片
  • 外用
    • 奶油
    • 沾醬
    • 軟膏
    • 噴

第9章 獸用感染疾病物市場：依動物類型分類

  • 水產養殖
    • 魚
    • 蝦
  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 山羊
    • 羊
    • 豬
  • 家禽
    • 雞肉
    • 火雞

第10章 獸用感染疾病物市場：依通路分類

  • 線上
  • 離線

第11章 獸用感染疾病物市場：依應用領域分類

  • 預防
  • 治療

第12章 獸用感染疾病物市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸用感染疾病物市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸用感染疾病物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AdvaCare Pharma
  • Ashish Life Science Pvt Ltd
  • Bimeda Holdings PLC
  • Biogenesis Bago
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Ltd
  • HIPRA SA
  • Huvepharma EOOD
  • Inovet Group
  • Intas Pharmaceuticals Ltd
  • Kyoritsu Seiyaku Corporation
  • Meiji Holdings Co Ltd
  • Merck & Co Inc
  • Norbrook Laboratories Ltd
  • Ourofino Saude Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd
  • Vee Remedies
  • Vetoquinol SA
  • Vivaldis Health and Foods
  • Zoetis Inc
  • Zydus Lifesciences Ltd
Product Code: MRR-2214614768CF

The Veterinary Anti-infectives Market is projected to grow by USD 23.07 billion at a CAGR of 14.03% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.20 billion
Estimated Year [2026] USD 10.45 billion
Forecast Year [2032] USD 23.07 billion
CAGR (%) 14.03%

Veterinary Anti-infectives Market Executive Summary

Veterinary anti-infectives are central to animal health, food security, and zoonotic disease control, spanning antibacterial, antifungal, antiviral, and related therapeutic classes used in livestock, poultry, aquaculture, and companion animals. Demand is supported by growth in animal protein consumption, expanding pet ownership, intensifying veterinary care, and the need to reduce disease-related productivity losses across farms, aquaculture systems, and veterinary clinics.

The veterinary anti-infectives market is increasingly shaped by antimicrobial resistance stewardship, prescription-only frameworks, residue monitoring, and evidence-based treatment protocols. Industry leaders are competing on differentiated formulations, targeted delivery, diagnostic-linked prescribing, pharmacovigilance, and compliance with guidance from regulators and public health bodies such as the FDA, EMA, WHO, WOAH, FAO, EFSA, and national veterinary authorities.

Transformative Shifts in the Veterinary Anti-infectives Landscape

The veterinary anti-infectives landscape is shifting from volume-driven treatment toward responsible, precision-based use. Regulatory actions such as the U.S. Veterinary Feed Directive, restrictions on medically important antimicrobials for production purposes, the European Union ban on routine antibiotic use for prophylaxis, and global antimicrobial resistance surveillance programs are accelerating the transition to prescription oversight, veterinary stewardship, and documented treatment justification.

At the same time, producers and veterinarians are adopting rapid diagnostics, improved biosecurity, vaccination, microbiome-supportive strategies, farm management software, and herd health analytics to reduce unnecessary antimicrobial exposure. This is changing product portfolios, favoring narrow-spectrum therapies, shorter withdrawal periods, improved palatability, injectable convenience, species-specific dosing, and formulations aligned with animal welfare, residue compliance, and food-chain safety expectations.

Cumulative Impact of Artificial Intelligence on Veterinary Anti-infectives

Artificial intelligence is creating cumulative value across veterinary anti-infectives by improving disease detection, susceptibility prediction, pharmacovigilance, and treatment decision support. AI-enabled imaging, sensor data, electronic medical records, diagnostic platforms, and farm management systems can identify early signs of infection, helping veterinarians intervene faster while supporting more selective antimicrobial use.

In research and commercial operations, AI accelerates compound screening, resistance pattern analysis, adverse event detection, literature surveillance, inventory planning, and prescribing workflow optimization. Its strongest near-term impact is in antimicrobial stewardship, where algorithm-assisted diagnostics, outbreak risk scoring, and treatment pathway support can reduce empirical prescribing, strengthen compliance documentation, and improve outcomes for livestock, aquaculture, and companion animals.

Key Regional Insights Across Major Veterinary Anti-infectives Markets

Asia-Pacific remains a high-priority region for veterinary anti-infectives because of large livestock populations, aquaculture intensity, rising companion animal care, and expanding veterinary infrastructure across China, India, Japan, South Korea, Australia, and Southeast Asia. The region's animal health priorities are shaped by poultry and swine production, dairy development, export-oriented aquaculture, and growing enforcement of residue and antimicrobial use requirements. North America is defined by mature veterinary channels, strong companion animal spending, FDA and Canadian regulatory oversight, transparent antimicrobial sales reporting, and producer investment in herd health, diagnostics, and biosecurity programs. Latin America is supported by Brazil and Mexico's significant beef, poultry, swine, and dairy sectors, where export compliance, animal productivity, and disease prevention remain important drivers of responsible anti-infective use.

Europe is strongly influenced by the EU One Health Action Plan, EMA antimicrobial categorization, farm-to-fork food safety rules, residue controls, and documented reductions in sales of veterinary antimicrobials reported through European monitoring programs. These policies continue to reinforce veterinarian-led prescribing, preventive herd health, and restricted use of critically important antimicrobials. The Middle East is expanding veterinary services alongside food security strategies, dairy modernization, poultry investments, and regulated import requirements for animals and animal products. Africa presents long-term need tied to livestock dependency, transboundary animal disease burden, rural veterinary access gaps, and the importance of quality-assured veterinary medicines in supporting food security and smallholder productivity.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is supported by poultry, swine, aquaculture, and dairy expansion, with governments increasingly aligning food safety, residue testing, and animal health programs with responsible antimicrobial use. The group's diverse production systems create demand for affordable, species-appropriate, and quality-assured veterinary anti-infectives supported by veterinary guidance and improved diagnostic access. The GCC is focused on food security, imported breeding stock, dairy modernization, camel and equine health, and regulated veterinary care, creating demand for high-quality anti-infectives with documented safety, traceability, and residue profiles.

The European Union remains one of the most stewardship-driven environments due to harmonized veterinary medicines regulation, One Health antimicrobial resistance strategies, pharmacovigilance requirements, and restrictions on routine prophylactic antibiotic use. BRICS economies combine large animal populations, expanding domestic pharmaceutical capacity, rising protein demand, and evolving regulatory enforcement, making responsible access and manufacturing quality key strategic themes. G7 markets emphasize innovation, diagnostics, digital veterinary tools, pharmacovigilance, and premium companion animal care, while NATO countries show overlap with advanced regulatory systems, resilient supply-chain planning, biosecurity readiness, and coordinated responses to animal disease threats that can affect food systems and public health.

Key Country Insights in Veterinary Anti-infectives

The United States and Canada benefit from advanced veterinary infrastructure, companion animal expenditure, livestock biosecurity programs, and transparent antimicrobial sales and distribution reporting, while Mexico and Brazil are important livestock-led markets shaped by export compliance, poultry and beef production, dairy modernization, and herd productivity. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong veterinary practice networks with strict stewardship expectations, residue controls, and mature livestock and companion animal care systems, while Russia remains influenced by domestic animal protein production, import substitution dynamics, and the need to maintain access to veterinary medicines across large production geographies.

China and India are pivotal due to scale in livestock, poultry, aquaculture, dairy, and evolving regulatory enforcement around veterinary drug quality, food safety, and antimicrobial resistance. Japan, Australia, and South Korea prioritize quality, traceability, prescription oversight, and responsible use. Australia's livestock export orientation, strong biosecurity culture, and residue compliance requirements reinforce demand for compliant therapies, while Japan's high-standard veterinary care and South Korea's modern companion animal and livestock systems support targeted anti-infective use with strong safety documentation.

Actionable Recommendations for Veterinary Anti-infectives Industry Leaders

Industry leaders should prioritize antimicrobial stewardship as a commercial advantage by investing in rapid diagnostics, susceptibility-linked prescribing tools, veterinarian education, and products designed for targeted therapy. Portfolio strategies should reduce dependence on broad-spectrum usage and emphasize label clarity, species-specific dosing, withdrawal-period compliance, pharmacokinetic evidence, palatability, adherence, and real-world safety documentation.

Manufacturers should strengthen regulatory intelligence across FDA, EMA, EU, and national frameworks while improving supply resilience for active pharmaceutical ingredients, excipients, and finished formulations. Partnerships with veterinary clinics, producer groups, diagnostic developers, academic networks, and digital health platforms can improve treatment outcomes, generate real-world evidence, strengthen pharmacovigilance, and support differentiated positioning across livestock, poultry, aquaculture, and companion animal channels.

Research Methodology for Veterinary Anti-infectives Insights

This executive analysis is based on secondary research from regulatory publications, veterinary medicine guidance, antimicrobial resistance surveillance programs, animal health policy documents, peer-reviewed literature, and public data from organizations including FDA, EMA, WOAH, WHO, FAO, EFSA, and national veterinary authorities. Market interpretation considers animal population trends, animal protein production, aquaculture development, pet care demand, prescribing rules, residue controls, pharmacovigilance requirements, and regional access dynamics.

Qualitative triangulation was applied across policy shifts, product positioning, distribution channels, treatment protocols, and end-user behavior. The methodology emphasizes verified indicators over unsupported estimates, with attention to antimicrobial stewardship, regulatory compliance, innovation pipelines, diagnostic adoption, supply-chain resilience, and commercial adoption patterns across livestock, poultry, aquaculture, and companion animal segments.

Conclusion: Responsible Growth in Veterinary Anti-infectives

The veterinary anti-infectives market is entering a more disciplined era where industry progress depends on balancing animal health needs with antimicrobial resistance mitigation. Demand remains resilient because infections directly affect livestock productivity, companion animal welfare, aquaculture performance, and food-chain continuity, but future value will increasingly come from precision, compliance, diagnostic integration, and evidence-based therapy.

Organizations that align innovation with One Health principles, regional regulation, responsible access, veterinarian-led stewardship, and transparent safety documentation will be best positioned to compete. The strongest opportunities will emerge where targeted anti-infectives, digital decision support, rapid diagnostics, and responsible use strategies converge to protect animal health, public health, and food security together.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Anti-infectives Market, by Product Type

  • 7.1. Antibiotics
    • 7.1.1. Aminoglycosides
    • 7.1.2. Beta Lactams
    • 7.1.3. Fluoroquinolones
    • 7.1.4. Macrolides
    • 7.1.5. Sulfonamides
    • 7.1.6. Tetracyclines
  • 7.2. Antifungals
    • 7.2.1. Azoles
    • 7.2.2. Polyenes
  • 7.3. Antiparasitics
    • 7.3.1. Acaricides
    • 7.3.2. Anthelmintics
    • 7.3.3. Insecticides

8. Veterinary Anti-infectives Market, by Route Of Administration

  • 8.1. Injectable
    • 8.1.1. Intramuscular
    • 8.1.2. Intravenous
    • 8.1.3. Subcutaneous
  • 8.2. Oral
    • 8.2.1. Pellets
    • 8.2.2. Powders
    • 8.2.3. Suspensions
    • 8.2.4. Tablets
  • 8.3. Topical
    • 8.3.1. Creams
    • 8.3.2. Dips
    • 8.3.3. Ointments
    • 8.3.4. Sprays

9. Veterinary Anti-infectives Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animal
    • 9.2.1. Cats
    • 9.2.2. Dogs
  • 9.3. Livestock
    • 9.3.1. Cattle
    • 9.3.2. Goats
    • 9.3.3. Sheep
    • 9.3.4. Swine
  • 9.4. Poultry
    • 9.4.1. Chicken
    • 9.4.2. Turkey

10. Veterinary Anti-infectives Market, by Distribution Channel

  • 10.1. Online
  • 10.2. Offline

11. Veterinary Anti-infectives Market, by Application

  • 11.1. Prophylactic
  • 11.2. Therapeutic

12. Veterinary Anti-infectives Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Veterinary Anti-infectives Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Anti-infectives Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AdvaCare Pharma
  • 16.2. Ashish Life Science Pvt Ltd
  • 16.3. Bimeda Holdings PLC
  • 16.4. Biogenesis Bago
  • 16.5. Boehringer Ingelheim International GmbH
  • 16.6. Ceva Sante Animale
  • 16.7. Dechra Pharmaceuticals PLC
  • 16.8. ECO Animal Health Group Plc
  • 16.9. Elanco Animal Health Incorporated
  • 16.10. Endovac Animal Health
  • 16.11. Hester Biosciences Ltd
  • 16.12. HIPRA SA
  • 16.13. Huvepharma EOOD
  • 16.14. Inovet Group
  • 16.15. Intas Pharmaceuticals Ltd
  • 16.16. Kyoritsu Seiyaku Corporation
  • 16.17. Meiji Holdings Co Ltd
  • 16.18. Merck & Co Inc
  • 16.19. Norbrook Laboratories Ltd
  • 16.20. Ourofino Saude Animal
  • 16.21. Phibro Animal Health Corporation
  • 16.22. SeQuent Scientific Ltd
  • 16.23. Vee Remedies
  • 16.24. Vetoquinol SA
  • 16.25. Vivaldis Health and Foods
  • 16.26. Zoetis Inc
  • 16.27. Zydus Lifesciences Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AZOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AZOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AZOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYENES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYENES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYENES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIPARASITICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTIPARASITICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIPARASITICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACARICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACARICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACARICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTHELMINTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTHELMINTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTHELMINTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INSECTICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INSECTICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INSECTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PELLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PELLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PELLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSPENSIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUSPENSIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSPENSIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SHRIMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SHRIMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SHRIMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL COMPANION ANIMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPANION ANIMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CHICKEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CHICKEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CHICKEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL TURKEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL TURKEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL TURKEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PROPHYLACTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PROPHYLACTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PROPHYLACTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 267. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 268. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 271. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 272. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 273. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 311. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 312. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 314. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 316. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 319. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 320. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 321. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 326. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 327. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 328. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 329. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 330. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 331. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 332. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 335. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 336. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 337. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 338. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 359. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
  • TABLE 360. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 361. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 362. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 363. CANADA VETERINARY ANTI-INFECTIVES MARK